Request Demo
Last update 29 Oct 2026
Harbin Pharmaceutical Group Sixth Pharm Factory
Subsidiary Company|2010|Heilongjiang Sheng, China
Subsidiary Company|2010|Heilongjiang Sheng, China
Last update 29 Oct 2026
Overview
Tags
Other Diseases
Nervous System Diseases
Infectious Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
100 Clinical Results associated with Harbin Pharmaceutical Group Sixth Pharm Factory
Login to view more data
Login to view more data
Analytical Methods
Girard reagent purification coupled with hollow-fiber-based stirring liquid microextraction followed by HPLC with diode array detection for determination of naphthoquinones in Qing Long Yi
Author: Xiaoli Wang ; Feng Niu ; Yuanyuan Zhou ; Chenggang Liu ; Haixue Kuang ; Yanqiu Jiang ; Bingyou Yang ; Yuxin Liu
Naphthoquinones all with carbonyl groups may react with the Girard reagent to form a water-soluble substance called hydrazone. These denatured naphthoquinones can recover lipid solubility transferred to the organic liquid layer.
100 Deals associated with Harbin Pharmaceutical Group Sixth Pharm Factory
Login to view more data
100 Translational Medicine associated with Harbin Pharmaceutical Group Sixth Pharm Factory
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 15 Nov 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
4
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free